OVER 25 MILLION PHONES STOLEN IN ONE YEAR- FG. (PHOTO).

Image
 Over 25 million phones stolen in one year – FG The Crime Experience and Security Perception Survey report of the National Bureau of Statistics, a Federal Government agency, shows that Nigeria recorded 25.35 million phone theft cases between May 2023 and April 2024. According to the report, this was the most common type of crime within the period under review. The report read, “The number of crimes experienced by individuals in Nigeria was analysed over a period of time. The results show that theft of phones (25,354,417) was the most common crime experienced by individuals, followed by consumer fraud (12,107,210) and assault (8,453,258). However, hijacking of cars (333,349) was the least crime experienced by individuals within the reference period.” It also noted that most phone theft cases occurred either at home or in a public place, and about 90 per cent of such cases were reported to the police. Despite the high rate of the incident being reported, only about 11.7 per cent of t...

ASTRA-ZENECA FINDS NO EVIDENCE OF INCREASED BLOOD CLOTH RISK FROM VACCINE.{PHOTO}.

 


(Reuters) - AstraZeneca Plc on Sunday said it had conducted a review of people vaccinated with its COVID-19 vaccine which has shown no evidence of an increased risk of blood clots.

The review covered more than 17 million people vaccinated in the European Union and United Kingdom.

“A careful review of all available safety data of more than 17 million people vaccinated in the European Union and UK with COVID-19 Vaccine AstraZeneca has shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis or thrombocytopenia, in any defined age group, gender, batch or in any particular country,” the statement said.

Authorities in Denmark, Norway and Iceland have suspended the use of the vaccine over clotting issues, while Austria stopped using a batch of AstraZeneca shots last week while investigating a death from coagulation disorders.

Ireland on Sunday temporarily suspended AstraZeneca’s COVID-19 vaccine “out of an abundance of caution”.

The drugmaker said additional testing has and is being conducted by the company and the European health authorities and none of the re-tests have shown cause for concern.

There are also no confirmed issues related to quality of any of its COVID-19 vaccine batches used across Europe and rest of the world, the company said.

Comments

Popular posts from this blog

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

SSANU, NASU THREATEN STRIKE OVER WITHHELD SALARIES. (PHOTO).